# A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis

> **NCT07709910** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fujian Shengdi Pharmaceutical Co., Ltd.** · enrollment: 382 (estimated)

## Conditions studied

- Participants With Obesity and Knee Osteoarthritis

## Interventions

- **DRUG:** Ribupatide Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07709910
- **Lead sponsor:** Fujian Shengdi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-11
- **Final completion:** 2028-12
- **Target enrollment:** 382 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709910, "A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07709910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*